Flat growth masks wage hikes and pricing pressure; AI momentum unproven

Delivered 16.1% OPM. Prior Q4 had ~170 bps one-offs. July wage hikes will dilute Q2 by ~85–100 bps.

Correct. Q1 FY26 was ~$140M. But Q1 traditionally weak; growth off depressed base.

QoQ constant currency +0.3%, rupee +2.3%. Deal pipeline strong but revenue is flat; pricing pressure acknowledged by management.

No segment detail in call. Management stated BFSI and LSS offset weakness but no numbers given.

Analyst Priyank Chheda challenges this; actual headcount still below pre-COVID. Management says 'process,' no firm timeline.

Prior guidance: 15%+ normalized. Achieved 16.1% in Q1 but with incoming wage hikes will dip to ~15% or below in Q2, cycling back to guided range, not sustainably higher.

Guided 30–40% addition by Q2 FY27 last quarter. Priyank Chheda presses hard; actual headcount still pre-COVID lows. Management now says 'process' and 'couple of quarters,' walking back Q2 commitment.

This quarter: 25% of code via agentic AI, Cogito MVP shown to 15+ clients, strategic AI engagements won (FS, banking, pharma). Prior quarter vague; now concrete wins and roadmap.

Manufacturing and E&U both soft. Expected to turn 'Q3 onwards' or 'in a couple of quarters,' but no firm commitment. Priyank asks how long; Angan says 'yoyo, give us couple quarters,' adding uncertainty.

Priyank aggressively challenges $300M cash holding (one-third of market cap) and lack of buyback/M&A plan. Chandru says Board will 'reward shareholders' and 'look at capability assets,' but no timeline or threshold disclosed.

Confident momentum will sustain. BFSI and LSS strong; Manufacturing weakness continues near-term but investing heavily; overall momentum should sustain. Deal signings up 20% YoY vs Q1 prior year.

Will push for 15%+ EBITDA. Achieved 16.1% Q1 but wage hikes from July (170–200 bps) will dilute Q2; expect to recover with productivity. Net of investments, expect 15% or slightly better.

Board will reward shareholders, pursue capability-based inorganic growth, maintain balance sheet strength. Management focused on organic momentum now.

Most deals hotly contested. Winning fair share. No material change in deal tenure; deals 18–24 months, long-term. First time seeing high AI component in deals.

Momentum = deal signings + healthy pipeline. Seeing reasonable uptick in pipeline and output/outcome-based deals with AI components. Can't give exact numbers; market very volatile. H1 will be much better than prior year H1 but won't quantify.

Is a process. Adding major muscle to sales globally. Sales domain headcount actually increased; support headcount rationalized. Will add significantly over next quarter or so. Can't give exact numbers on new clients.

Reasonably confident if order book momentum continues and we invest right, revenues will come. Built some momentum, expect it in Q2. Renewals protected, not losing any; pricing pressure only because AI-driven work has productivity gains.

Unbilled was higher than expected due to delayed documentation on two clients. Regularized in Q1, collections improved, DSO improved to 55 days. Working to improve unbilled further.

Pricing pressure from AI productivity gains. Clients demanding productivity baked into deals upfront. Mismatch will take couple of quarters to streamline. Industry phenomenon, not Birlasoft alone. Over next 3–4 quarters expect convergence as industry stabilizes.

Always looking at capability building. Will not do revenue aggregation M&A. Focused on AI platform building and vertical-specific AI platforms. When asset comes along, will evaluate. Right now focused on delivering organic growth; don't want management distracted.

Top 5, 10, 20 accounts have grown. Beyond 36 accounts revenue shrunk. Rationalization almost done. Focus on growing top 30, 40 accounts. Will add salespeople for new real estate outside top 200 clients. 36 accounts = 80% of revenue, so ample existing real estate to tap.

That's our endeavor. Can't give guidance. Q3, Q4, Q1 have been good in order book. Goal to deliver similar or more in Q2. Based on initial estimate, feeling good about it.

ETR should be under 30%, in 29–30% range.

BFSI momentum to continue broadly; LSS will bounce back. Manufacturing and E&U will need couple of quarters. Working heavily, measuring order book; when order book comes, revenue will come. If troubled sectors recover, H2 could be better than H1.

Management repeatedly deflected on specific revenue targets. H1 deal signings will be 'much better' than prior year H1, but no numerical commit.

Wage impact expected to be half (85–100 bps) on Q2 P&L; full impact 170–200 bps recoverable over year via productivity gains. Q2 margins likely to dip to ~15% or below before recovery.

Clients demanding 'productivity gains baked in upfront' to AI deals. Management admits TCV 20% up but revenue flat; pricing mismatch will take 'couple quarters to streamline.' Industry-wide but Birlasoft lacks pricing power.

Manufacturing and E&U = ~50% of revenue, both soft. Recovery expected 3Q onwards but no firm commitment. Manufacturing cyclic; structural client spending pattern issues. Analysts note this is drag on full-year growth.

July 2026 wage hike across all associates: 170–200 bps impact estimated. Q2 P&L expected to see ~half impact (85–100 bps) with full recovery via productivity improvements 'as we go forward' (vague timeline).

36 accounts = 80% of revenue. Active accounts at 213 (lowest ever); rationalization of tail complete or ongoing. New sales team to expand real estate outside top 200, but timeline vague ('couple of quarters'). Risk: if top 36 have cyclic downturn, no breadth to offset.

Cogito AI platform shown to 15+ clients (MVP stage). 25% of code via agentic AI tools. Early wins in AI deals (FS, banking, pharma). But no evidence of large-scale adoption or revenue uplift yet. Risk: hype vs delivery if deals don't convert or margins remain pressured.